Authorized Generics Debate Heats Up On Hill, But May Need FTC Study To Boil
Executive Summary
Authorized generics have prompted the reintroduction of several bills and questions about FDA's regulatory actions - but any legislative movement likely depends on a pending Federal Trade Commission report